Benzinga’s Top Pre-Market Gainers (ANDS, CCRT, IDIX, CXDC)

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) rose 26.44% to $3.30 in the pre-market session. Anadys Pharmaceuticals, Inc. announced that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care (SOC) achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC. The 52-week trading range for ANDS is $1.44 - $6.45. In the last six months, ANDS has gained over 16%.

CompuCredit Holdings Corp (NASDAQ: CCRT) climbed 16.55% to $6.48 in the pre-market session. CompuCredit Holdings announced that it has commenced a cash tender offer for its outstanding 3.625% convertible senior notes due 2025 up to a total purchase price of $100.0 million, and for shares of its outstanding common stock at a purchase price of $7.00 per share. In the previous trading session, CCRT closed at $5.56. CCRT has surged over 50% in the last year.

Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) 16.18 % to $4.74 in the pre-market session. Idenix Pharmaceuticals, Inc. announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients. The 52-week trading range for IDIX is $1.81 - $5.45. Idenix Pharmaceuticals closed at $4.08 in the last trading session.

China XD Plastics Co Ltd (NASDAQ: CXDC) moved up 1.45% to $7.29 in the pre-market session. China XD Plastics Co Ltd announced that it expects fiscal 2010 revenues to be in the range between $170 million to $200 million, and non-GAAP adjusted net income to be in the range between $27 million to $30 million, excluding any non-cash charge related to the change in fair value of the existing derivative liabilities and stock-based compensation. The 52 week trading range for CXDC is $ 1.30 - $15.00. China XD Plastics closed at $6.60 in the previous trading session.